Thorax Online First, published on October 18, 2016 as 10.1136/thoraxjnl-2016-209170 Editorial

13 24 are elevated in human ARDS. Thorax: first published as 10.1136/thoraxjnl-2016-209170 on 18 October 2016. Downloaded from What drives to the alveoli However, the new evidence that the neutro- phil chemotactic activity in BAL fluid from in ARDS? patients with ARDS is highly attributable to CCL2 and CCL7 and that CCL2/7 potenti- 1,2 3,4 Rachel L Zemans, Michael A Matthay ates the chemotactic activity of CXCL8 is novel and important. Moreover, given that the neutrophils used in the influx into the extravascular prototypical neutrophil .12 assays were isolated from the blood of compartments of the is a defining CXC chemokines are elevated in patients healthy volunteers, which likely express less characteristic of the Acute Respiratory with ARDS13 and animal models of CCR2thanthoseactivelymigratinginto Distress Syndrome (ARDS).1 During injury,712and CXCL8 levels are predictive the lungs during ARDS, the role of CCL2 ARDS, circulating neutrophils become of disease development,14 severity15 and andCCL7inneutrophilchemotaxisin primed, resulting in reduced deformability mortality.16 However, although CXC che- ARDS may even be underestimated. and retention within the pulmonary capil- mokines are responsible for much of the These studies raise several mechanistic lary bed23followed by migration across neutrophil recruitment to the lungs during questions. First, the extent to which CCL2/ the endothelium, through the interstitium lung injury, blockade of CXCL8 or CXCL1/ 7 are directly chemotactic for neutrophils and across the epithelium into the air- 2 prevents some but not all neutrophil is unclear, as the degree of neutrophil spaces.4 As neutrophils migrate, they may recruitment.712Additional CXC chemo- chemotaxis induced by recombinant CCL2 become activated to phagocytose invading kines such as CXCL5 (LIX/ENA-78), or CCL7 was small and did not reach statis- pathogens and release oxidants, proteases CXCL12 (SDF-1) and CXCL15 (lungkine), tical significance, even with concentrations and neutrophil extracellular traps, all of as well as other mediators such as LTB4 and of recombinant chemokines much higher which play a role in killing pathogens. C5a, also are neutrophil chemoattractants.8 than those detected in the BAL fluid of Although neutrophils may migrate into Chambers et al have previously pub- patients with ARDS. Still, reasonable con- the airspaces without inducing an increase lished elegant animal studies demonstra- centrations of CCL2/7 do enhance the in permeability under certain con- ting that the CC chemokines CCL2 chemotactic potency of CXCL8. While the ditions,5 in ARDS neutrophils and their (MCP-1) and CCL7 (MCP-3), classically authors speculate that enhanced receptor toxic mediators can cause tissue injury, chemotactic for ,11 contribute occupancy may contribute to this synergis- including an increase in lung epithelial to neutrophil recruitment in acute lung tic effect, future studies should explore the – and endothelial permeability6 9 which injury. After challenge with lipopolysac- mechanism underlying this effect as well as leads to the influx of protein-rich alveolar charide (LPS) or live bacteria, CCL2 and whether CCL2/7 also acts in synergy with oedema and arterial hypoxaemia.10 In CCL7 were rapidly upregulated in the other CXC (or CC) chemokines. In add- fact, mortality from ARDS correlates with lungs, the CC receptors CCR1 ition, the cellular sources of CCL2 and the extent of neutrophilia in the lung.1 and CCR2 were expressed on neutrophils, CCL7 and the mechanisms that induce Treatment for ARDS is mainly supportive, and blockade of CCL2 and/or CCL7 atte- their synthesis are not completely consisting of low tidal volume ventilation nuated neutrophil recruitment.17 18

understood. Reports suggest the alveolar http://thorax.bmj.com/ and fluid restriction, approaches which In Thorax, Williams et al19 tested their and bronchial epithelium as likely have substantially improved outcomes. experimental findings in patients, asking sources,17 23 25 and expression appears to However, to further improve outcomes, whether CCL2 and CCL7 are similarly be regulated by proteinase-activated recep- specific therapies to limit inflammatory important in neutrophil recruitment in tors.17 18 In addition, while the authors lung injury while preserving host defense ARDS. Both CCL2 and CCL7 were ele- have demonstrated that CCL2/7 are dir- are needed. Therefore, it is critical that vated in the bronchoalveolar lavage (BAL) ectly chemotactic for neutrophils, there we understand the mechanisms regulating fluid of patients with ARDS and the neu- may be additional mechanisms through fl neutrophil recruitment, priming, activa- trophil chemotactic activity of BAL uid which CCL2/7 induce neutrophil recruit- on October 3, 2021 by guest. Protected copyright. tion and effector functions. was as much attributable to either CCL2 ment, such as via activation of resident Leucocyte chemokines are classified into or CCL7 as to CXCL8. Although CCL2 alveolar macrophages or epithelial cells to several families based on the position of and CCL7 were weaker neutrophil che- secrete CXC chemokines or by inducing cysteine (C) residues: CXC, CC, C and moattractants than CXCL8 when chemo- recruitment, which in turn may CX3C.11 Neutrophil migration has classic- taxis towards recombinant chemokines facilitate neutrophil recruitment.26 In addi- ally been thought to be driven by the CXC was tested, CCL2 and CCL7 each signifi- tion, investigation of the extent to which chemokines, with CXCL8 ( 8) in cantly enhanced neutrophil chemotaxis to these CC chemokines induce chemotaxis humans and its orthologs CXCL1 (KC) and CXCL8, suggesting that the effect is syn- and prime and activate neutrophils and CXCL2 (MIP2) in mice being the ergistic. Finally, their studies demonstrated prolong neutrophil life span, as CXCL8 that the CXC can, is warranted. Along these lines,

1 CXCR1 was downregulated while the CC additional studies should be done to deter- Department of Medicine, National Jewish Health, chemokine receptor CCR2 was upregu- Denver, Colorado, USA; 2Department of Medicine, mine whether blockade of these University of Colorado Denver, Aurora, Colorado, USA; lated as neutrophils migrated from the chemokines also mitigates lung injury (per- 3The Cardiovascular Research Institute, University of bloodstream into the airspaces (figure 1). meability) in human ARDS models, as is California San Francisco, San Francisco, California, This study was rigorously performed, 7 4 the case with CXCL8 blockade. Finally, USA; Departments of Medicine and Anesthesiology, leading to well justified conclusions. The the effect of CCL2/7 inhibition, with asso- University of California, San Francisco, California, USA findings are consistent with prior literature ciated blockade of neutrophil influx, on Correspondence to Professor Michael A Matthay, demonstrating that CCL2 and CCL7 can the ability of the lungs to clear bacteria Departments of Medicine and Anesthesiology, 505 20 21 Parnassus Avenue, M-917, San Francisco, CA 94143- function as neutrophil chemoattractants, should be tested in ARDS models of live 22 23 0624, USA; [email protected] including in models of lung injury, and bacterial infection.

Zemans RL, Matthay MA. Thorax Month 2016 Vol 0 No 0 1 Copyright Article author (or their employer) 2016. Produced by BMJ Publishing Group Ltd (& BTS) under licence. Editorial Thorax: first published as 10.1136/thoraxjnl-2016-209170 on 18 October 2016. Downloaded from

Figure 1 Neutrophil influx in ARDS. In patients with acute lung injury from ARDS, resident lung cells such as macrophages secrete chemokines that induce neutrophils or polymorphonuclear cells (PMN) to migrate from the bloodstream into the airspaces. Classically, neutrophil migration has been thought to be driven by CXC chemokines, with CXCL8 being the protypical neutrophil chemokine, inducing migration by acting on its receptors, mainly CXCR1 in humans. Chambers et al have demonstrated that two members of the CC family of chemokines, CCL2 and CCL7, are upregulated in the lungs of patients with ARDS. Their receptor, CCR2, is upregulated on neutrophils as they migrate from the vasculature into the airspaces, while CXCR1 is downregulated. Moreover, these CC chemokines act in synergy with CXCL8 to induce neutrophil influx. As neutrophils migrate into the lungs, they become activated, releasing toxic mediators such as reactive oxygen species (ROS), proteases and neutrophil extracellular traps (NETs), which function to kill invading pathogens but also may cause epithelial and endothelial injury, leading to the development of protein-rich alveolar oedema. Figure prepared by Diana Lim. http://thorax.bmj.com/

The holy grail of ARDS therapy would likely to be a critical determinant of the activity of others could theoretically miti- be to limit neutrophil recruitment and specific chemokine-receptor pathways gate neutrophil-dependent tissue damage priming/activation while preserving host involved. In mice, both CCL2 and CCL7 without impairing host defense. However, defence. However, neutrophil function is were important neutrophil chemokines in because the mediators that induce neutro- complex, requiring migration, priming the LPS model, while in the phil chemotaxis and activation are Streptococcus pneumoniae

and activation, each potentially induced model, CCL7 complex, redundant and pathogen- on October 3, 2021 by guest. Protected copyright. by a variety of mediators, for their full but not CCL2 was implicated.17 Whether dependent, targeting neutrophils is still microbicidal and cytotoxic effects. A different neutrophil chemokines are likely to be challenging as a basic treat- better understanding of the precise role of important in human ARDS of different ment for ARDS, especially once the tissue each mediator is a prerequisite for the aetiologies remains to be determined. It injury is established. Indeed, clinical trials design of novel therapies that would inter- would also be interesting to know of agents directed towards reducing neu- vene at one or more steps to limit tissue whether the levels and relative chemotac- trophil migration and/or activation have damage while preserving microbicidal tic activity of the CC chemokines, or not improved outcomes.28 Ultimately, a function. In this context, this manuscript expression of their receptors, correlates multifaceted approach aimed at attenuat- has made an important contribution. with neutrophil numbers, disease severity ing inflammatory tissue injury while pre- Because ARDS is heterogeneous, it is or prognosis, as is the case for CXC che- serving host defense as well as promoting likely that therapies will need to be perso- mokines.15 16 Finally, neutrophils are the resolution of inflammation,29 repair of nalised to the individual patient. In the increasingly recognised to be heteroge- the injured lung30 and the reabsorption of patients with ARDS studied here, there neous in terms of cell surface marker oedema fluid is likely to be necessary. was substantial variability in chemokine expression and function;27 different Acknowledgements The authors thank Diana Lim levels, the extent to which each chemo- subsets of neutrophils may be differen- for her work in preparing figure 1. kine accounted for the overall chemotactic tially responsive to CC and CXC fl Funding RLZ: NIH HL131608, Boettcher Foundation, activity of the BAL uid, and neutrophil chemokines. American Heart Association, University of Colorado expression of CXC and CC chemokine A targeted and personalised approach Department of Medicine, MAM: NHLBI HL51856, receptors. Host factors surely contribute, to inhibit one or more mediators of neu- NHLBI HL51856. but the specific aetiology of ARDS is trophil function while permitting the Competing interests None declared.

2 Zemans RL, Matthay MA. Thorax Month 2016 Vol 0 No 0 Editorial

Provenance and peer review Commissioned; 9 Simon RH, DeHart PD, Todd RF III. 21 Xu LL, McVicar DW, Ben-Baruch A, et al. Monocyte Thorax: first published as 10.1136/thoraxjnl-2016-209170 on 18 October 2016. Downloaded from externally peer reviewed. Neutrophil-induced injury of rat pulmonary alveolar chemotactic protein-3 (MCP3) interacts with multiple epithelial cells. J Clin Invest 1986;78:1375–86. leukocyte receptors: binding and signaling of MCP3 To cite Zemans RL, Matthay MA. Thorax Published 10 Matthay MA, Ware LB, Zimmerman GA. The acute through shared as well as unique receptors on Online First: [please include Day Month Year] respiratory distress syndrome. J Clin Invest 2012;122: monocytes and neutrophils. Eur J Immunol doi:10.1136/thoraxjnl-2016-209170 2731–40. 1995;25:2612–17. 11 Bhatia M, Zemans RL, Jeyaseelan S. Role of 22 Balamayooran G, Batra S, Theivanthiran B, et al. chemokines in the pathogenesis of acute lung injury. Intrapulmonary G-CSF rescues neutrophil recruitment Am J Respir Cell Mol Biol 2012;46:566–72. to the lung and neutrophil release to blood in 12 Frevert CW, Huang S, Danaee H, et al. Functional Gram-negative bacterial infection in MCP-1-/- mice. characterization of the rat chemokine KC and its J Immunol 2012;189:5849–59. ▸ http://dx.doi.org/10.1136/thoraxjnl-2016-208597 importance in neutrophil recruitment in a rat model of 23 Michalec L, Choudhury BK, Postlethwait E, et al. pulmonary inflammation. JImmunol1995;154:335–44. CCL7 and CXCL10 orchestrate oxidative – Thorax 2016;0:1 3. 13 Goodman RB, Strieter RM, Martin DP, et al. stress-induced neutrophilic lung inflammation. doi:10.1136/thoraxjnl-2016-209170 Inflammatory in patients with persistence J Immunol 2002;168:846–52. of the acute respiratory distress syndrome. 24 Kambas K, Markiewski MM, Pneumatikos IA, et al. REFERENCES Am J Respir Crit Care Med 1996;154(Pt 1):602–11. C5a and TNF-alpha up-regulate the expression of 1 Steinberg KP, Milberg JA, Martin TR, et al. Evolution 14 Donnelly SC, Strieter RM, Kunkel SL, et al. tissue factor in intra-alveolar neutrophils of patients of bronchoalveolar cell populations in the adult Interleukin-8 and development of adult respiratory with the acute respiratory distress syndrome. respiratory distress syndrome. Am J Respir Crit Care distress syndrome in at-risk patient groups. Lancet J Immunol 2008;180:7368–75. Med 1994;150:113–22. 1993;341:643–7. 25 Standiford TJ, Kunkel SL, Phan SH, et al. Alveolar 2 Worthen GS, Schwab B III, Elson EL, et al. Mechanics 15 Groeneveld AB, Raijmakers PG, Hack CE, et al. macrophage-derived cytokines induce monocyte of stimulated neutrophils: cell stiffening induces -related neutrophil elastase and the chemoattractant protein-1 expression from human retention in capillaries. Science 1989;245:183–6. severity of the adult respiratory distress syndrome. pulmonary type II-like epithelial cells. J Biol Chem 3 Summers C, Singh NR, White JF, et al. Pulmonary 1995;7:746–52. 1991;266:9912–18. retention of primed neutrophils: a novel protective 16 Miller EJ, Cohen AB, Nagao S, et al. Elevated levels 26 Maus U, von Grote K, Kuziel WA, et al. The role of host response, which is impaired in the acute of NAP-1/interleukin-8 are present in the airspaces of CC chemokine receptor 2 in alveolar monocyte and respiratory distress syndrome. Thorax 2014;69:623–9. patients with the adult respiratory distress syndrome neutrophil immigration in intact mice. Am J Respir 4 Zemans RL, Colgan SP, Downey GP. Transepithelial and are associated with increased mortality. Am Rev Crit Care Med 2002;166:268–73. migration of neutrophils: mechanisms and Respir Dis 1992;146:427–32. 27 Williams AE, Chambers RC. The mercurial nature of implications for acute lung injury. Am J Respir Cell 17 Mercer PF, Williams AE, Scotton CJ, et al. neutrophils: still an enigma in ARDS? Am J Physiol Mol Biol 2009;40:519–35. Proteinase-activated receptor-1, CCL2, and CCL7 Lung Cell Mol Physiol 2014;306:L217–30. 5 Martin TR, Pistorese BP, Chi EY, et al.Effectsof regulate acute neutrophilic lung inflammation. 28 Iwata K, Doi A, Ohji G, et al. Effect of neutrophil leukotriene B4 in the human lung. Recruitment of Am J Respir Cell Mol Biol 2014;50:144–57. elastase inhibitor (sivelestat sodium) in the treatment neutrophils into the alveolar spaces without a change in 18 José RJ, Williams AE, Mercer PF, et al. Regulation of of acute lung injury (ALI) and acute respiratory protein permeability. J Clin Invest 1989;84:1609–19. neutrophilic inflammation by proteinase-activated distress syndrome (ARDS): a systematic 6 Smedly LA, Tonnesen MG, Sandhaus RA, et al. receptor 1 during bacterial pulmonary infection. review and meta-analysis. Intern Med Neutrophil-mediated injury to endothelial cells. J Immunol 2015;194:6024–34. 2010;49:2423–32. Enhancement by endotoxin and essential role of 19 Williams AE, José RJ, Mercer PF, et al. Evidence for 29 Fang X, Abbott J, Cheng L, et al. Human neutrophil elastase. J Clin Invest 1986;77:1233–43. chemokine synergy during neutrophil migration in mesenchymal stem (stromal) cells promote the 7 Folkesson HG, Matthay MA, Hebert CA, et al. Acid ARDS. Thorax. Published Online First: 5 Aug 2016. resolution of acute lung injury in part through aspiration-induced lung injury in rabbits is mediated doi:10.1136/thoraxjnl-2016-208597 Lipoxin A4. J Immunol 2015;195:875–81. by interleukin-8-dependent mechanisms. J Clin Invest 20 Johnston B, Burns AR, Suematsu M, et al. Chronic 30 Zemans RL, Briones N, Campbell M, et al. Neutrophil fl 1995;96:107–16. in ammation upregulates chemokine receptors and transmigration triggers repair of the lung epithelium http://thorax.bmj.com/ 8 Bosmann M, Grailer JJ, Ruemmler R, et al. induces neutrophil migration to monocyte via beta-catenin signaling. Proc Natl Acad Sci USA Extracellular histones are essential effectors of C5aR- chemoattractant protein-1. J Clin Invest 2011;108:15990–5. and C5L2-mediated tissue damage and inflammation 1999;103:1269–76. in acute lung injury. FASEB J 2013;27:5010–21. on October 3, 2021 by guest. Protected copyright.

Zemans RL, Matthay MA. Thorax Month 2016 Vol 0 No 0 3